Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rujietai capsule for mammary gland hyperplasia (Phase IV, single-arm, China)
ChiCTR2100046694Phase 4Recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Rujietai in breast hyperplasia, sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoints: Routine blood test, Urinary routine and 4 more. Started Mar 2021; status: recruiting.
02
Drugs
Rujietai
03
Conditions
breast hyperplasia
Beyond the preview
Go deeper on ChiCTR2100046694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046694.